Green Cross Holdings Corporation (005257.KS)

KRW 23150.0

(1.09%)

Total Assets Summary of Green Cross Holdings Corporation

  • Green Cross Holdings Corporation's latest annual total assets in 2023 was 2643.31 Billion KRW , up 4.66% from previous year.
  • Green Cross Holdings Corporation's latest quarterly total assets in 2024 Q2 was 2729.52 Billion KRW , up 1.66% from previous quarter.
  • Green Cross Holdings Corporation reported annual total assets of 2525.53 Billion KRW in 2022, up 2.57% from previous year.
  • Green Cross Holdings Corporation reported annual total assets of 2462.14 Billion KRW in 2021, up 14.44% from previous year.
  • Green Cross Holdings Corporation reported quarterly total assets of 2729.52 Billion KRW for 2024 Q2, up 1.66% from previous quarter.
  • Green Cross Holdings Corporation reported quarterly total assets of 2677.75 Billion KRW for 2023 Q3, up 108.52% from previous quarter.

Annual Total Assets Chart of Green Cross Holdings Corporation (2023 - 2007)

Historical Annual Total Assets of Green Cross Holdings Corporation (2023 - 2007)

Year Total Assets Total Assets Growth
2023 2643.31 Billion KRW 4.66%
2022 2525.53 Billion KRW 2.57%
2021 2462.14 Billion KRW 14.44%
2020 2151.39 Billion KRW 9.8%
2019 1959.29 Billion KRW 13.69%
2018 1723.4 Billion KRW 1.16%
2017 1703.58 Billion KRW 9.86%
2016 1550.61 Billion KRW 9.57%
2015 1415.12 Billion KRW 6.37%
2014 1330.35 Billion KRW 20.47%
2013 1104.26 Billion KRW 15.7%
2012 954.37 Billion KRW 10.93%
2011 860.35 Billion KRW 16.06%
2010 741.29 Billion KRW 3.97%
2009 713.02 Billion KRW 29.79%
2008 549.37 Billion KRW 29.07%
2007 425.63 Billion KRW 0.0%

Peer Total Assets Comparison of Green Cross Holdings Corporation

Name Total Assets Total Assets Difference
ORIENT BIO Inc. 96.98 Billion KRW -2625.409%
Green Cross Holdings Corporation 3737.7 Billion KRW 29.28%
Pharmicell Co., Ltd. 99.19 Billion KRW -2564.865%
Green Cross Corporation 2643.31 Billion KRW 0.0%
GeneOne Life Science, Inc. 151 Billion KRW -1650.45%
Celltrion, Inc. 19917.53 Billion KRW 86.729%
Samsung Biologics Co.,Ltd. 16046.19 Billion KRW 83.527%
SK bioscience Co.,Ltd. 1852.43 Billion KRW -42.694%
SK Biopharmaceuticals Co., Ltd. 723.17 Billion KRW -265.517%
Prestige BioPharma Limited 711.72 Billion KRW -271.398%